HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
8th Edition of
International Cancer Conference
September 18 -20, 2025 | Online Event
Event Book
Event program
Scientific Program
About
We are delighted to announce the successful conclusion of the 8th Edition of International Cancer Conference, held virtually from September 18–20, 2025. This online edition brought together a global community of oncologists, researchers, clinicians, healthcare professionals, advocates, and industry leaders who shared pioneering insights and advancements across cancer research, diagnostics, therapeutics, and patient care. Over three highly engaging days, the conference featured keynote presentations, panel discussions, interactive Q&A sessions, and poster showcases, offering a comprehensive look at the evolving landscape of oncology.
Scientific Committee Members
Rajvir Dahiya
University of California San Francisco, United States
Jianhua Luo
University of Pittsburgh School of Medicine, United States
Michael Thompson
University of Toronto, CanadaSpeakers
David Boswick
Rampart Health, United States
Romi Gupta
The University of Alabama at Birmingham, United States
Joel Raj
Anne Burnett Marion School of Medicine at Texas Christian University, United States
Camille Charlotte Balanca
Genentech, Inc, United States
Patricia Tai
UpToDate, Canada
Dhuha Al Sajee
The University Health Network, Canada
Camelia Quek
Melanoma Institute Australia, Australia
Jose Manuel Cervera Grau
Preclinical Lab and Computational Drug Discovery Program, Relayer Biotech Inc, SpainGallery
Cancer Conference 2023 | London, UK
Cancer Conference 2019 | London, UK
Cancer Conference 2018 | Rome, Italy
Cancer Conference 2016 | Dubai, UAE
Reviews
Cancer Conference 2018 | Rome, Italy
Cancer Conference 2016 | Dubai, UAE
Magnus Group Conferences Reveiws
Nursing Conference 2018 | Rome, Italy
Nursing Conference 2016 | Dubai, UAE
Title : Multiplexed detection of ovarian cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Role of mRNA genomics technology in cancer screening, diagnosis, prognosis, precision medicine, and gene therapy
Rajvir Dahiya, University of California San Francisco, United States
Title : Serum based machine learning models to assess the risk of liver cancer
Jianhua Luo, University of Pittsburgh School of Medicine, United States
Title : Update on PSMA PET scans: Initial and salvage treatment of nodal/distant metastases in prostate cancer
Patricia Tai, UpToDate, Canada
Title : Use of VOCT and machine learning to diagnose and understand skin cancer
Frederick Silver, Rutgers, The State University of New Jersey, United States
Title : Targeting the post-translationally generated epitopes to fight cancer
Michele Mishto, The Francis Crick Institute, United Kingdom